Jane Street Group, LLC 180 Life Sciences Corp. Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$0.81 - $2.53 $39,528 - $123,463	-48,800 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$2.53 - $3.9 $222,133 - $342,420	-87,800 Reduced 64.28%	48,800 $126,000
Q4 2021 Feb 15, 2022	BUY	$3.27 - $6.38 $243,615 - $475,310	74,500 Added 119.97%	136,600 $533,000
Q3 2021 Nov 16, 2021	SELL	$5.11 - $10.81 $307,622 - $650,762	-60,200 Reduced 49.22%	62,100 $336,000
Q2 2021 Aug 16, 2021	BUY	$6.7 - $11.98 $819,410 - $1.47 Million	122,300 New	122,300 $1.22 Million

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.